Search results
The privileged status of orphan medicines in Germany
Pharmaceutical Technology via Yahoo Finance· 2 months agoIn Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question this market’s desirability for orphan drug...
Analysis-Prices for new US drugs rose 35% in 2023, more than the previous year
Reuters via Yahoo Finance· 4 months agoPharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022,...
Amgen dives deeper into rare disease drugs with $27.8 billion Horizon deal
Reuters via Yahoo Finance· 2 years ago(Reuters) -Amgen Inc on Monday agreed to buy Horizon Therapeutics Plc in a deal valued at $27.8...
CHMP approves backing for first acanthamoeba keratitis treatment
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoThe European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Where Will Recursion Pharmaceuticals Be in 5 Years?
Motley Fool via Yahoo Finance· 2 months agoAs a biotech that's planning to go big on artificial intelligence (AI) for drug development, Recursion Pharmaceuticals (NASDAQ: RXRX) is a decidedly...
FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source
Reuters via Yahoo Finance· 1 year agoAmgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. Amgen...
Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoPanbela Therapeutics, Inc. (NASDAQ:PBLA) Q4 2022 Earnings Call Transcript March 16, 2023 Operator:...
Ocugen (OCGN) Q1 2023 Earnings Call Transcript
Motley Fool· 1 year agoJoining me today are Ocugen's chairman, CEO and co-founder; Dr. Shankar Musunuri, who will provide a business update; and our chief financial officer and...
Billionaire Steve Cohen Pulls the Trigger on These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 1 year agoThe big news in the markets this week was the release of the January inflation data. Inflation came...
Q3 2023 Inovio Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Thomas Hong; IR; Inovio Pharmaceuticals, Inc. Jacqui Shea; President & CEO; Inovio Pharmaceuticals, Inc. Mike Sumner; Chief Medical Officer; Inovio Pharmaceuticals, Inc. Mark Twyman ...